Bulletin 2009/07 - European Patent Office
13.12.2012 • Views
Share Embed Flag

Bulletin 2009/07 - European Patent Office

Bulletin 2009/07 - European Patent Office

Bulletin 2009/07 - European Patent Office

SHOW MORE
SHOW LESS
ePAPER READ
DOWNLOAD ePAPER
application.epo.org

Create successful ePaper yourself

Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.

START NOW

(A61K) I.1(1)<br />

A61K 31/00 → (51) C12Q 1/68<br />

(51) A61K 31/01 (11) 2 020 997 A2*<br />

A61K 31/353 A61K 31/555<br />

A61P 13/08 A61P 35/00<br />

(25) En (26) En<br />

(21) <strong>07</strong>725220.3 (22) 15.05.20<strong>07</strong><br />

(84) AT BE BG CH CY CZ DE DK EE ES FI FR GB<br />

GR HU IE IS IT LI LT LU LV MC MT NL PL PT<br />

RO SE SI SK TR<br />

AL BA HR MK RS<br />

(86) EP 20<strong>07</strong>/004302 15.05.20<strong>07</strong><br />

(87) WO 20<strong>07</strong>/131767 20<strong>07</strong>/47 22.11.20<strong>07</strong><br />

(88) 03.04.2008<br />

(30) 15.05.2006 EP 06009926<br />

(54) • NEUE WIRKSTOFFE GEGEN PROSTATA-<br />

KARZINOM<br />

• NOVEL ACTIVES AGAINST PROSTATE<br />

CARCINOMA<br />

• NOUVEAUX AGENTS ACTIFS CONTRE LE<br />

CARCINOME DE LA PROSTATE<br />

(71) DSM IP Assets B.V., Het Overloon 1, 6411<br />

TE Heerlen, NL<br />

(72) GORALCZYK, Regina, 79639 Grenzach-<br />

Wyhlen, DE<br />

SILER, Ulrich, 79639 Grenzach-Wyhlen, DE<br />

WERTZ, Karin, 79618 Rheinfelden, DE<br />

(74) Schwander, Kuno, DSM Nutritional Products<br />

Ltd., Wurmisweg 576, 4303 Kaiseraugst, CH<br />

(51) A61K 31/04 (11) 2 020 998 A1*<br />

A61K 31/195<br />

(25) En (26) En<br />

(21) <strong>07</strong>795298.4 (22) 23.05.20<strong>07</strong><br />

(84) AT BE BG CH CY CZ DE DK EE ES FI FR GB<br />

GR HU IE IS IT LI LT LU LV MC MT NL PL PT<br />

RO SE SI SK TR<br />

AL BA HR MK RS<br />

(86) US 20<strong>07</strong>/012410 23.05.20<strong>07</strong><br />

(87) WO 20<strong>07</strong>/139897 20<strong>07</strong>/49 06.12.20<strong>07</strong><br />

(30) 23.05.2006 US 802916 P<br />

(54) • ZUSAMMENSETZUNGEN UND VERFAH-<br />

REN ZUR HEMMUNG DER ENDOTHELIA-<br />

LEN STICKOXID-SYNTHASE-AKTIVITÄT<br />

• COMPOSITIONS AND METHODS FOR THE<br />

INHIBITION OF ENDOTHELIAL NITRIC<br />

OXIDE SYNTHASE ACTIVITY<br />

• COMPOSITIONS ET MÉTHODES POUR<br />

INHIBER L'ACTIVITÉ DES SYNTHASES<br />

ENDOTHÉLIALES DU MONOXYDE<br />

D'AZOTE<br />

(71) University of Utah Research Foundation, 615<br />

Arapeen Drive, Salt Lake City, Utah 84108,<br />

US<br />

(72) SAMLOWSKI, Wolfram, Salt Lake City, UT<br />

84102, US<br />

KONDAPANENI, Muralidhar, Salt Lake City,<br />

UT 84112, US<br />

MCGREGOR, John R., Salt Lake City, UT<br />

84102, US<br />

(74) Roberts, Michael Austin, Reddie & Grose 16<br />

Theobalds Road, London WC1X 8PL, GB<br />

A61K 31/04 → (51) A01N 43/36<br />

A61K 31/045 → (51) A23K 1/16<br />

A61K 31/<strong>07</strong> → (51) C12Q 1/68<br />

A61K 31/132 → (51) C<strong>07</strong>C 225/20<br />

A61K 31/167 → (51) C<strong>07</strong>C 237/46<br />

A61K 31/185 → (51) A23K 1/16<br />

A61K 31/19 → (51) A01N 37/10<br />

Europäisches <strong>Patent</strong>blatt<br />

<strong>European</strong> <strong>Patent</strong> <strong>Bulletin</strong><br />

<strong>Bulletin</strong> européen des brevets<br />

A61K 31/192 → (51) C<strong>07</strong>C 59/68<br />

A61K 31/195 → (51) A61K 9/20<br />

A61K 31/195 → (51) A61K 31/04<br />

A61K 31/196 → (51) C<strong>07</strong>C 59/68<br />

A61K 31/197 → (51) A61K 31/40<br />

A61K 31/197 → (51) A61K 38/01<br />

(51) A61K 31/198 (11) 2 020 999 A1*<br />

(25) En (26) En<br />

(21) <strong>07</strong>728341.4 (22) 20.04.20<strong>07</strong><br />

(84) AT BE BG CH CY CZ DE DK EE ES FI FR GB<br />

GR HU IE IS IT LI LT LU LV MC MT NL PL PT<br />

RO SE SI SK TR<br />

AL BA HR MK RS<br />

(86) EP 20<strong>07</strong>/053882 20.04.20<strong>07</strong><br />

(87) WO 20<strong>07</strong>/122190 20<strong>07</strong>/44 01.11.20<strong>07</strong><br />

(30) 21.04.2006 PL 37951206<br />

(54) • ZUSAMMENSETZUNGEN MIT ALPHA-<br />

KETOGLUTARAT UND IHRE VERWEN-<br />

DUNG ZUR MODULIERUNG DER MUS-<br />

KELLEISTUNG<br />

• COMPOSITIONS COMPRISING ALPHA-<br />

KETOGLUTARATE AND THEIR USE FOR<br />

MODULATING MUSCLE PERFORMANCE<br />

• NOUVEAUX PROCEDES ET LEUR UTILI-<br />

SATION<br />

(71) SGP & SONS AB, Lilla Varvsgatan 14, 211 15<br />

Malmö, SE<br />

(72) PIERZYNOWSKI, Stefan, 211 14 Malmö, SE<br />

(74) Bengtsson, Peggy Katrin, et al, Albihns AB P.<br />

O. Box 4289, 203 14 Malmö, SE<br />

A61K 31/198 → (51) A61K 38/01<br />

A61K 31/215 → (51) C<strong>07</strong>C 405/00<br />

A61K 31/343 → (51) C<strong>07</strong>D 213/64<br />

A61K 31/351 → (51) C<strong>07</strong>D 213/64<br />

A61K 31/352 → (51) C<strong>07</strong>D 309/38<br />

A61K 31/353 → (51) A61K 31/01<br />

A61K 31/37 → (51) A61K 9/22<br />

A61K 31/381 → (51) C<strong>07</strong>D 213/64<br />

(51) A61K 31/40 (11) 2 021 000 A2*<br />

A61K 45/06 A61K 31/4015<br />

A61K 31/403 A61K 31/416<br />

A61K 31/4166 A61K 31/4184<br />

A61K 31/505 A61P 25/00<br />

A61K 31/197 A61K 31/4178<br />

A61K 31/44 A61K 31/55<br />

(25) En (26) En<br />

(21) <strong>07</strong>783549.4 (22) 09.05.20<strong>07</strong><br />

(84) AT BE BG CH CY CZ DE DK EE ES FI FR GB<br />

GR HU IE IS IT LI LT LU LV MC MT NL PL PT<br />

RO SE SI SK TR<br />

AL BA HR MK RS<br />

(86) US 20<strong>07</strong>/068609 09.05.20<strong>07</strong><br />

(87) WO 20<strong>07</strong>/134136 20<strong>07</strong>/47 22.11.20<strong>07</strong><br />

(88) 28.08.2008<br />

(30) 09.05.2006 US 746859 P<br />

17.<strong>07</strong>.2006 US 8<strong>07</strong>594 P<br />

20.10.2006 US 551667<br />

(54) • NEUROGENESE MITTELS ANGIOTENSIN-<br />

MODULATION<br />

• NEUROGENESIS BY MODULATING<br />

ANGIOTENSIN<br />

38<br />

Anmeldungen<br />

Applications<br />

Demandes (<strong>07</strong>/<strong>2009</strong>) 11.02.<strong>2009</strong><br />

• NEUROGENÈSE PAR MODULATION DE<br />

L'ANGIOTENSINE<br />

(71) Braincells, Inc., 10835 Road to the Cure,<br />

Suite 150, San Diego, CA 92121, US<br />

(72) BARLOW, Carrolee, Del Mar, CA 92014, US<br />

CARTER, Todd, A., San Diego, CA 92129, US<br />

TREUNER, Kai, San Diego, CA 92122, US<br />

LORRAIN, Kym, I., San Diego, CA 92124, US<br />

(74) Roques, Sarah Elizabeth, J.A. Kemp & Co. 14<br />

South Square Gray's Inn, London WC1R 5JJ,<br />

GB<br />

A61K 31/40 → (51) C<strong>07</strong>D 209/20<br />

(51) A61K 31/4015 (11) 2 021 001 A2*<br />

A61K 31/4412 A61P 25/28<br />

A61P 43/00<br />

(25) En (26) En<br />

(21) <strong>07</strong>783945.4 (22) 18.05.20<strong>07</strong><br />

(84) AT BE BG CH CY CZ DE DK EE ES FI FR GB<br />

GR HU IE IS IT LI LT LU LV MC MT NL PL PT<br />

RO SE SI SK TR<br />

AL BA HR MK RS<br />

(86) US 20<strong>07</strong>/069279 18.05.20<strong>07</strong><br />

(87) WO 20<strong>07</strong>/137181 20<strong>07</strong>/48 29.11.20<strong>07</strong><br />

(88) <strong>07</strong>.08.2008<br />

(30) 19.05.2006 US 801949 P<br />

(54) • PHOSPHODIESTERASE-4-HEMMER FÜR<br />

KOGNITIVE UND MOTORISCHE REHABI-<br />

LITATION<br />

• PHOSPHODIESTERASE 4 INHIBITORS FOR<br />

COGNITIVE AND MOTOR REHABILITATION<br />

• INHIBITEURS DE LA PHOSPHODIESTÉ-<br />

RASE 4 UTILISÉS DANS LA RÉHABILITA-<br />

TION COGNITIVE ET MOTRICE<br />

(71) Helicon Therapeutics, Inc., 7473 Lusk Blvd.,<br />

San Diego, CA 92121, US<br />

(72) HALLAM, Thomas, M., Huntington, NY<br />

11743, US<br />

BOURTCHOULADZE, Rusiko, New York, NY<br />

10033, US<br />

TULLY, Timothy, Cold Spring Harbor, NY<br />

11724, US<br />

(74) Becker, Philippe, Cabinet Becker & Associés<br />

25, rue Louis Le Grand, 75002 Paris, FR<br />

A61K 31/4015 → (51) A61K 31/40<br />

A61K 31/4015 → (51) C<strong>07</strong>D 401/06<br />

A61K 31/4015 → (51) C<strong>07</strong>D 401/12<br />

A61K 31/4025 → (51) C<strong>07</strong>D 401/12<br />

A61K 31/403 → (51) A61K 31/40<br />

A61K 31/41 → (51) C<strong>07</strong>D 209/20<br />

A61K 31/416 → (51) A61K 31/40<br />

A61K 31/4166 → (51) A61K 31/40<br />

(51) A61K 31/4178 (11) 2 021 002 A2*<br />

A61K 9/28 A61K 9/20<br />

(25) En (26) En<br />

(21) <strong>07</strong>724794.8 (22) 02.05.20<strong>07</strong><br />

(84) AT BE BG CH CY CZ DE DK EE ES FI FR GB<br />

GR HU IE IS IT LI LT LU LV MC MT NL PL PT<br />

RO SE SI SK TR<br />

AL BA HR MK RS<br />

(86) EP 20<strong>07</strong>/003868 02.05.20<strong>07</strong><br />

(87) WO 20<strong>07</strong>/128478 20<strong>07</strong>/46 15.11.20<strong>07</strong><br />

(88) <strong>07</strong>.02.2008<br />

(30) 04.05.2006 EP 06009223<br />

(54) • PHARMAZEUTISCHE ZUSAMMENSET-<br />

ZUNG<br />

• PHARMACEUTICAL COMPOSITION<br />

• COMPOSITION PHARMACEUTIQUE

logo

products

Resources

Company

Terms of service
Privacy policy
Cookie policy
Cookie settings
Imprint
Change language
Made with love in Switzerland
© 2024 Yumpu.com all rights reserved

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!